Nakamoto, Inc. (NAKA)
5.00
-0.79
(-13.64%)
USD |
NASDAQ |
Nov 13, 16:00
4.93
-0.07
(-1.40%)
After-Hours: 19:59
Nakamoto Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.31% |
| March 31, 2026 | -224.6% |
| December 31, 2025 | 84.11% |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | -87.68% |
| December 31, 2024 | -9.82% |
| September 30, 2024 | -84.55% |
| June 30, 2024 | -94.16% |
| Date | Value |
|---|---|
| March 31, 2024 | 7.62% |
| December 31, 2023 | -14.09% |
| September 30, 2023 | -18.29% |
| June 30, 2023 | -19.35% |
| March 31, 2023 | 12.89% |
| December 31, 2022 | -8.37% |
| September 30, 2022 | -101.1% |
| June 30, 2022 | 27.61% |
| March 31, 2022 | 31.55% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Astrana Health, Inc. | 10.54% |
| Agilon Health, Inc. | 6.00% |
| Starling Oncology, Inc. | 17.17% |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 75.40% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.31% |
| Return on Assets | -41.38% |
| Return on Invested Capital | -42.98% |
| Profit Margin (Quarterly) | -4.45K% |
| Return on Net Operating Assets | -49.43% |